Stock Events

Stock Events

Q/C Technologies 

$1.7900
71
-$0.09-4.79% Friday 20:00
+$0.01+0.56%Friday 23:27After hours

Statistics

Day High
1.7901
Day Low
1.775
52W High
8.94
52W Low
1.7661
Volume
22,303
Avg. Volume
-
Mkt Cap
14.66M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

1JanExpected
Q4 0
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-14.98MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow QCLS. It's not an investment recommendation.
IonQ
7
IONQ
Amazon
6
AMZN
NVIDIA
6
NVDA
Palantir Technologies
6
PLTR

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap180.64B
Gilead Sciences is a biopharmaceutical company that competes with MyMD in the development of treatments for viral diseases, inflammatory and fibrotic diseases, which overlaps with MyMD's focus on immune-mediated diseases.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie competes in the immunology and oncology sectors, directly challenging MyMD's efforts in developing therapies for immune system diseases and cancer.
AMGEN
AMGN
Mkt Cap233.78B
Amgen is a biotech firm focusing on novel therapies in areas like inflammation, which competes with MyMD's research into immune system modulation.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol Myers Squibb operates in the biopharmaceutical field, focusing on cancer and immune system disorders, directly competing with MyMD's therapeutic areas.
Merck
MRK
Mkt Cap366B
Merck is known for its work in pharmaceuticals and vaccines, including treatments for immune system disorders, making it a competitor to MyMD.
Pfizer
PFE
Mkt Cap159.36B
Pfizer develops and manufactures drugs and vaccines, including for autoimmune diseases, competing with MyMD's focus on immune system modulation.
Regeneron Pharmaceuticals
REGN
Mkt Cap81.77B
Regeneron Pharmaceuticals specializes in medicines for serious conditions, including immune-mediated diseases, directly competing with MyMD's focus areas.
Novartis
NVS
Mkt Cap292.35B
Novartis focuses on a broad range of healthcare areas, including advanced therapies in immunology and oncology, competing with MyMD.
Biogen
BIIB
Mkt Cap32.28B
Biogen focuses on neurology and rare diseases but also competes in the broader biopharmaceutical market against companies like MyMD.
Vertex Pharmaceuticals
VRTX
Mkt Cap137.3B
Vertex Pharmaceuticals concentrates on treating the underlying causes of diseases in areas like cystic fibrosis, which involves modulation of the immune system, indirectly competing with MyMD.

About

Q/C Technologies Inc is engaged in building blockchain and cryptocurrency infrastructure that is faster and more energy-efficient through quantum-class laser-based computing. The company uses laser-based processors inspired by quantum technology that can solve complex problems. By combining photonic computing with cryptocurrency systems, the company creates powerful and sustainable solutions for the next generation of blockchain applications.
Show more...
CEO
Joshua N. Silverman
Employees
2
Country
United States
ISIN
US62856X3008
WKN
000A41E0S

Listings

F
DE
DQS.F
XNAS
US
QCLS
MU
DE
DQS.MU
LSE
GB
0A8D.LSE

0 Comments

Share your thoughts

FAQ

What is Q/C Technologies stock price today?▼
The current price of QCLS is $1.79 USD — it has decreased by -4.79% in the past 24 hours. Watch Q/C Technologies stock price performance more closely on the chart.
What is Q/C Technologies stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Q/C Technologies stocks are traded under the ticker QCLS.
What is Q/C Technologies market cap?▼
Today Q/C Technologies has the market capitalization of 14.66M
What is Q/C Technologies revenue for the last year?▼
Q/C Technologies revenue for the last year amounts to 0 USD.
What is Q/C Technologies net income for the last year?▼
QCLS net income for the last year is -14.98M USD.
How many employees does Q/C Technologies have?▼
As of September 05, 2026, the company has 2 employees.
In which sector is Q/C Technologies located?▼
Q/C Technologies operates in the Technology sector.
When did Q/C Technologies complete a stock split?▼
The last stock split for Q/C Technologies was on September 02, 2025 with a ratio of 1:100.
Where is Q/C Technologies headquartered?▼
Q/C Technologies is headquartered in NEW YORK, United States.